Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Short term Debt (2016 - 2020)

Historic Short term Debt for Fortress Biotech (FBIO) over the last 6 years, with Q2 2020 value amounting to $413000.0.

  • Fortress Biotech's Short term Debt changed N/A to $413000.0 in Q2 2020 from the same period last year, while for Jun 2020 it was $413000.0, marking a year-over-year change of. This contributed to the annual value of $27000.0 for FY2019, which is 9727.55% down from last year.
  • According to the latest figures from Q2 2020, Fortress Biotech's Short term Debt is $413000.0.
  • Fortress Biotech's Short term Debt's 5-year high stood at $991000.0 during Q4 2018, with a 5-year trough of $16000.0 in Q1 2019.
  • Its 5-year average for Short term Debt is $375125.0, with a median of $305500.0 in 2016.
  • In the last 5 years, Fortress Biotech's Short term Debt plummeted by 9727.55% in 2019 and then surged by 33125.0% in 2020.
  • Fortress Biotech's Short term Debt (Quarter) stood at $481000.0 in 2016, then plummeted by 35.76% to $309000.0 in 2017, then skyrocketed by 220.71% to $991000.0 in 2018, then crashed by 97.28% to $27000.0 in 2019, then surged by 1429.63% to $413000.0 in 2020.
  • Its last three reported values are $413000.0 in Q2 2020, $69000.0 for Q1 2020, and $27000.0 during Q4 2019.